# The duplexity of insulin: The integrated bioinformatics analysis and machine learning identified key genes for type 2 diabetes

**Authors:** Nan Gao, Xiteng Chen, Jun Yang, Yuanfeng Jiang, Shaochong Bu, Xiaomei Bai, Zhenyu Kou, Chunjun Li, Fang Tian

PMC · DOI: 10.1016/j.bbrep.2025.102099 · 2025-06-24

## TL;DR

This study uses bioinformatics and machine learning to show that insulin therapy for type 2 diabetes has both benefits and risks at the genetic level.

## Contribution

The study reveals the dual genetic effects of insulin therapy using integrated machine learning and bioinformatics analysis.

## Key findings

- Insulin therapy reduces inflammation and oxidative stress by downregulating IL-6 and proteasome.
- Insulin has a bidirectional effect, causing vascular complications but also reducing inflammation.
- Eight key genes, including IL-6, were identified as important in insulin's effects on T2DM.

## Abstract

Insulin therapy is still the most important treatment for T2DM, but the discussion about whether insulin brings more benefits or harms to T2DM patients has not stopped. Therefore, we used high-throughput RNA sequencing to investigate the role of insulin in T2DM and its molecular changes.

We collected peripheral blood samples from 16 patients with T2DM, and performed RNA-seq on peripheral blood mononuclear cells. Bioinformatics analysis and machine learning were uesd to identify the key differential genes and transcription factor networks. In addition, we performed the flow cytometry and staining to observe ROS level and endothelial-monocyte adhesion in PBMCs of both groups.

A total of 529 differential genes were identified by bioinformatics analysis. 8 genes were identified as key genes, among which IL-6 had high importance in the random forest model. In transcription factor analysis, IL-6, RETN, CTSG and ELANE have abundant transcriptional regulatory relationships. Flow cytometry showed that ROS production, phagocytosis, leukocyte adhesion in insulin treatment group were lower than that in non-insulin treatment group.

Insulin therapy is bidirectional, it can cause islet B cell damage and vascular complications, but also can reduce the level of inflammation and oxidative stress.

•The integrated machine learning and bioinformatics analysis.•Revealing the two-sided nature of insulin at the genetic level.•Downregulation of IL-6 and proteasome reduces inflammation and oxidative stress.•Despite the side effects, insulin therapy was generally favorable.

The integrated machine learning and bioinformatics analysis.

•Revealing the two-sided nature of insulin at the genetic level.

•Downregulation of IL-6 and proteasome reduces inflammation and oxidative stress.

•Despite the side effects, insulin therapy was generally favorable.

## Linked entities

- **Genes:** IL6 (interleukin 6) [NCBI Gene 3569], RETN (resistin) [NCBI Gene 56729], CTSG (cathepsin G) [NCBI Gene 1511], ELANE (elastase, neutrophil expressed) [NCBI Gene 1991]
- **Diseases:** type 2 diabetes (MONDO:0005148), T2DM (MONDO:0005148)

## Full-text entities

- **Genes:** RETN (resistin) [NCBI Gene 56729] {aka ADSF, FIZZ3, RENT, RETN1, RSTN, XCP1}, CTSG (cathepsin G) [NCBI Gene 1511] {aka CATG, CG}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, ELANE (elastase, neutrophil expressed) [NCBI Gene 1991] {aka ELA2, GE, HLE, HNE, NE, PMN-E}
- **Diseases:** inflammation (MESH:D007249), vascular complications (MESH:D003925), type 2 diabetes (MESH:D003924)
- **Chemicals:** ROS (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12242453/full.md

---
Source: https://tomesphere.com/paper/PMC12242453